Effects of N-methyl-D-aspartate agonists and antagonists in rats discriminating amphetamine

Behavioural Pharmacology

Volumn 12, Issue 5, 2001, Pages 317-324

  Gaiardi, Margherita ^a   Gubellini, C ^a   Dall Olio, R ^a   Gandolfi, O ^a   Bartoletti, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Amphetamine; CGP 43487; D cycloserine; Dizocilpine; Drug discrimination; NMDA agonists; NMDA antagonists; Rat

Indexed keywords

2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID; 2 AMINO 4 METHYL 5 PHOSPHONO 3 PENTENOIC ACID ETHYL ESTER; CYCLOSERINE; DEXAMPHETAMINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; MALE; NONHUMAN; PSYCHOPHARMACOLOGY; RAT; TRAINING;

EID: 0034774736     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200109000-00002     Document Type: Article

References (46)

1. Interactions between N-methyl-D-aspartate receptor antagonists and the discriminative stimulus effects of morphine in rats
2. Discrimination of ethanol in rats: Effects of nicotine, diazepam, CGP 40116, and 1-(m-chlorophenyl)-biguanide
3. Analysis of transformations
4. Dopamine ligands and the stimulus effects of amphetamine: Animal models versus human laboratory data
5. Competitive NMDA receptor antagonists attenuate the behavioural and neurochemical effects of amphetamine in mice
6. 9-tetrahydrocannabinol: Mechanistic studies
7. Differential behavioural and neurochemical effects of competitive and non-competitive NMDA receptor antagonists in rats
8. 2 agonists
9. 2 dopamine receptor blockers in the rat
10. The NMDA modulator D-cycloserine inhibits dopamine-mediated behaviours in the rat
11. The competitive NMDA antagonists CGP43487 and APV potentiate dopaminergic function
12. 2 mediated behaviours in intact rats
13. Influence of some drugs of abuse on the discriminative stimulus properties of amphetamine
14. B receptor ligands on the psychostimulant-induced discriminative stimuli in rats
15. Modulation of the stimulus effects of morphine by D-amphetamine
16. Evidence for perceptual masking of the discriminative morphine stimulus
17. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia
18. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia
19. Effects of N-methyl-D-aspartate antagonists in rats discriminating different doses of cocaine: Comparison with direct and indirect dopamine agonists
20. Modulation of the discriminative stimulus and rate-altering effects of cocaine by competitive and noncompetitive N-methyl-D-aspartate antagonists
21. A dopaminergic-glutamatergic basis for the action of amphetamine and cocaine
22. MK-801 inhibits methamphetamine-induced conditioned place preference and behavioural sensitisation to apomorphine in mice
23. Dopamine, the prefrontal cortex and schizophrenia
24. N-methyl-D-aspartate antagonists and drug discrimination
25. N-methyl-D-aspartate antagonism and phencyclidine-like activity: A drug discrimination analysis
26. Effects of phencyclidine-type drugs in rats discriminating fentanyl from saline: Pharmacological and behavioural characterisation of intermediate levels of drug selection
27. Effects of the NMDA antagonist, dizocilpine, in various drug discriminations: Characterisation of intermediate levels of drug lever selection
28. Comparison of competitive and uncompetitive NMDA receptor antagonists with regard to monoaminergic neuronal activity and behavioural effects in rats
29. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801
30. A comparison of the discriminable CNS effects of ketamine, phencyclidine and pentobarbital
31. Apomorphine increases ethanol discrimination
32. Relationship between the discriminative stimulus properties and subjective effects of drugs
33. Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration?
34. 2 dopamine receptors in the behavioural effects of cocaine
35. Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitisation
36. The impact of a competitive and a non-competitive NMDA receptor antagonist on dopaminergic neurotransmission in the rat ventral tegmental area and substantia nigra
37. MK-801 attenuates the dopamine-releasing but not the behavioural effects of methamphetamine: An in vivo microdialysis study
38. Effects of competitive and noncompetitive N-methyl-D-aspartate (NMDA) antagonists in rats trained to discriminate NMDA from saline
39. Pentobarbital-like discriminative stimulus effects of N-methyl-D-aspartate antagonists
40. A psychomotor stimulant theory of addiction
41. Blockade of the locomotor stimulant effects of cocaine and methamphetamine by glutamate antagonists
42. Discriminative stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a partial agonist of the strychnine-insensitive modulatory site of the N-methyl-D-aspartate receptor
43. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline
44. MK-801 does not prevent acute stimulatory effects of amphetamine or cocaine on locomotor activity or extracellular dopamine levels in rat nucleus accumbens